Charles River Laboratories CRL Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses.
The official record: Charles River Laboratories’s 10-K, filed February 18, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's effective income tax rate reconciliation nondeductible expense impairment losses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's effective income tax rate reconciliation nondeductible expense impairment losses?
- Charles River Laboratories (CRL) reported effective income tax rate reconciliation nondeductible expense impairment losses of 48.5% in Q4 2024.
- What does effective income tax rate reconciliation nondeductible expense impairment losses mean?
- The tax rate impact caused by impairment losses that cannot be deducted for tax purposes.
- How do you interpret effective income tax rate reconciliation nondeductible expense impairment losses?
- An increase in this metric signals higher tax expenses due to non-deductible asset write-downs, negatively impacting net income.
- How does effective income tax rate reconciliation nondeductible expense impairment losses compare across companies?
- Standard reconciliation item for companies undergoing significant restructuring or asset impairment cycles.